| 【英語論文】 |
| |
原著論文 |
| |
|
1. Kondo E, Ikeda T, Izutsu K, Chihara D, Shimizu-Koresawa R, Fujii N, Sakai T, Kondo T, Kubo K, Kato Y, Akasaka T, Fukuda T, Ichinohe T, Atsuta Y, Suzumiya J and Suzuki R; Adult Lymphoma Working Group of the Japan Society for Hematopoietic Cell Transplantation: High-Dose Chemotherapy with Autologous Stem Cell Transplantation in Primary Central Nervous System Lymphoma: Data From the Japan Society for Hematopoietic Cell Transplantation Registry. Biology of Blood and Marrow Transplantation, 25, 899-905, 2019. |
| |
|
2. Okamura-Shiki I, Moriguchi M, Uehara T, Fukaya M, Kakuda Y, Nakanuma Y and Ikeda T; Levothyroxine tablet (Thyradin-S)-induced autoimmune-like hepatitis following post-transplant Hashimoto’s thyroiditis in a patient after allogenic bone marrow transplantation. Leukemia and Lymphoma, 17, 1-3, 2019. |
| |
|
3. Kondo E, Ikeda T, Goto H, Nishikori M, Maeda N, Matsumoto K, Kitagawa H, Noda N, Sugimoto S, Hara J; Pharmacokinetics of thiotepa in high-dose regimens for autologous hematopoietic stem cell transplantation in Japanese patients with pediatric tumors or adult lymphoma. Cancer Chemotherapy and Pharmacology, 84, 849-860, 2019. |
| |
|
4. Aoyama T, Yoshitsugu K, Fukaya M, Kume T, Kawashima M, Nakajima K, Arai H, Imataki O, Enami T, Tatara R, Ikeda T; Benefit of reducing body weight loss with a nutritional support pathway in patients undergoing allogeneic hematopoietic stem cell transplantation. Medical Science Monitor Basic Research, 25, 187-198, 2019 |
| |
|
5. Shimomura Y, Hara M, Tachibana T, Ohashi K, Sakura T, Fukuda T, Nakazawa H, Iwato K, Kanda Y, Ikeda T, Eto T, Kanda J, Ichinohe T, Atsuta Y, Ishikawa T and Ishiyama K; Outcomes of second allogeneic haematopoietic stem cell transplantation in patients with relapse of myelodysplastic syndrome. British Journal of Haematology, 186, 86-90, 2019 |
| |
|
6. Ikeda T, Mori K, Kawamura K, Mori T, Hagiwara S, Ueda Y, Kahata K, Uchida N, Tsukada N, Murakami S, Yamamoto M, Takahashi T, Ichinohe T, Onizuka M, Atsuta Y, Kanda Y, Okamoto S, Sunami K and Takamatsu H; Comparison between autologous and allogeneic stem cell transplantation as salvage therapy for multiple myeloma relapsing/progressing after autologous stem cell transplantation. Hematological Oncology, 37, 586-594, 2019 |
| |
|
7. Attal M, Richardson P G, Rajkunar S V, et al. ; Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study. The Lancet, 394, 2096-2107, 2019. |
| |
|
